G&W Laboratories Company Profile

Background

Founded in 1919 by Carl Greenblatt, G&W Laboratories, Inc. is a family-owned pharmaceutical company headquartered in South Plainfield, New Jersey. The company's mission is to alleviate human suffering by developing, manufacturing, and marketing high-quality pharmaceutical products. G&W Laboratories emphasizes integrity, respect, and service, aiming to provide affordable and effective medicines while contributing positively to the community.

Key Strategic Focus

G&W Laboratories specializes in the development and manufacturing of generic pharmaceutical products, with a particular emphasis on topical dermatology treatments. The company is committed to delivering affordable, high-quality medications to meet the needs of patients and healthcare providers. G&W Laboratories operates manufacturing facilities in New Jersey, Pennsylvania, and North Carolina, ensuring a broad reach within the pharmaceutical market.

Financials and Funding

As of June 2025, G&W Laboratories reported annual revenues in the range of $100 million to $1 billion. The company has made significant investments to enhance its manufacturing capabilities, including a $17 million investment in a solid oral dosage product manufacturing facility in Sellersville, Pennsylvania. Additionally, G&W Laboratories allocated $3.5 million for additional equipment to further bolster production capacity.

Pipeline Development

G&W Laboratories maintains a diversified portfolio of approximately 35 self-labeled generic topical dermatology products currently marketed and sold in the U.S. The company also has an active pipeline in various stages of development, focusing on expanding its offerings in the dermatology sector.

Technological Platform and Innovation

The company has invested in state-of-the-art manufacturing facilities and equipment to enhance production capabilities. This includes a $17 million investment in a solid oral dosage product manufacturing facility and a $3.5 million allocation for additional equipment.

Leadership Team

G&W Laboratories is led by CEO Aaron Greenblatt, the great-grandson of founder Carl Greenblatt. Under his leadership, the company continues to uphold its mission of alleviating human suffering through the development and manufacturing of high-quality pharmaceutical products.

Leadership Changes

In 2015, Aaron Greenblatt assumed the role of CEO, succeeding his father, Ronald Greenblatt, who remains Chairman of the Board. This transition marked the continuation of family leadership into the fourth generation.

Competitor Profile

Market Insights and Dynamics

The generic pharmaceutical market is highly competitive, with numerous companies vying for market share. G&W Laboratories operates within this dynamic landscape, focusing on delivering high-quality, affordable medications to meet the needs of patients and healthcare providers.

Competitor Analysis

Key competitors in the generic pharmaceutical sector include:

CSPC Pharmaceutical Group: A pharmaceutical company engaged in drug development and production.

McKesson Europe: An international trading company providing logistics and services in the pharmaceutical and healthcare sector.

Sandoz: A company operating in generic and biosimilar medicines.

Macleods Pharmaceuticals: A company involved in pharmaceutical research, development, and manufacturing.

These companies, like G&W Laboratories, focus on developing and manufacturing generic pharmaceutical products, contributing to the competitive landscape of the industry.

Strategic Collaborations and Partnerships

In November 2018, G&W Laboratories entered into an agreement with Avista Capital Partners for the acquisition of its extended topicals and dermatology business unit. This transaction allowed G&W Laboratories to focus on other business areas, including investments to drive efficiency in the pharmaceutical value chain and contract manufacturing operations.

Operational Insights

G&W Laboratories' strategic investments in manufacturing facilities and equipment have enhanced its production capabilities, allowing the company to meet the growing demand for generic pharmaceutical products. The company's commitment to quality and affordability positions it competitively within the generic pharmaceutical market.

Strategic Opportunities and Future Directions

G&W Laboratories aims to continue expanding its product portfolio and manufacturing capabilities to meet the evolving needs of the pharmaceutical market. The company's focus on quality, affordability, and community engagement positions it well for future growth and success.